Article Information
PubMed
Published By
History
- Received June 20, 2022
- Revision received August 19, 2022
- Accepted August 29, 2022
- Published online October 10, 2022.
Copyright & Usage
Copyright © 2022 Smith et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Brittany L. Smith1,
- Tess A. Guzman1,
- Alexander H. Brendle1,2,
- Collin J. Laaker1,3,
- Alexis Ford1,
- Adam R. Hiltz1,
- Junfang Zhao4,
- Kenneth D. R. Setchell4,5 and
- Teresa M. Reyes1
- 1Department of Pharmacology & Systems Physiology, University of Cincinnati, Cincinnati, Ohio 45267
- 2College of Nursing, University of Cincinnati, Cincinnati, Ohio 45221
- 3Neuroscience Training Program, University of Wisconsin-Madison, Madison, Wisconsin 53705
- 4Clinical Mass Spectrometry Laboratory, Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229-3026
- 5Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267
- Correspondence should be addressed to Brittany L. Smith at smithb103{at}nku.edu.
Author contributions
Author contributions: B.L.S., C.J.L., and T.M.R. designed research; B.L.S., T.A.G., A.H.B., C.J.L., A.F., J.Z., and K.D.R.S. performed research; A.R.H. and K.D.R.S. contributed unpublished reagents/analytic tools; B.L.S., C.J.L., and J.Z. analyzed data; B.L.S. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This research was supported by National Institutes of Health/National Institute on Drug Abuse Grants K99 DA049908 (to B.L.S.) and R21-DA-049253 (to T.M.R.).
Funding
HHS | NIH | National Institute on Drug Abuse (NIDA)
K99 DA049908; R21 DA049253
Other Version
- You are viewing the most recent version of this article.
- previous version (October 10, 2022).
Online Impact
Article usage
In this issue
Perinatal Morphine Exposure Leads to Sex-Dependent Executive Function Deficits and Microglial Changes in Mice
